• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281412
Device Problems Difficult to Remove (1528); Physical Resistance (2578); Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/01/2017
Event Type  malfunction  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Event Description
On (b)(6) 2017, a gore® excluder® aaa endoprosthesis featuring c3® delivery system was being prepared for advancement when resistance was reportedly noted when loading the device onto the guidewire.It was reported the device was not tracking well on the guidewire and was very difficult to advance.It was reported a decision was made to remove the device from the guidewire, but during retraction the device could not be removed.Force was reportedly applied to remove the device from the guidewire, after which point the catheter began to separate at the trailing olive / polyimide wire junction.It was reported that after the catheter started to separate, it was able to be removed from the guidewire.No obstructions were reportedly noted within the catheter itself.It was reported there were no kinks noted in the guidewire after removal of the delivery catheter.However, it was decided to use a new guidewire, and another device was able to be advanced and was successfully implanted.The procedure was completed with no adverse events to the patient.
 
Manufacturer Narrative
Udi: (b)(4).The device was discarded at the facility and was not available for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
claire west
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6843113
MDR Text Key85115837
Report Number3007284313-2017-00216
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/16/2020
Device Catalogue NumberRLT281412
Device Lot Number16506940
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/05/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/07/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/17/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient Weight117
-
-